A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors

High Risk of Symptomatic Cardiac Events in Childhood Cancer Survivors

(2012) Helena J. van der Pal et al.   JOURNAL OF CLINICAL ONCOLOGY

A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors

(2012) Margaret E. Macy et al.   PEDIATRIC BLOOD & CANCER

Liposomal pegylated doxorubicin and oxaliplatin as salvage chemotherapy in patients with metastatic gastric cancer treated earlier

(2010) Francesco Recchia et al.   ANTI-CANCER DRUGS

A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: A Children's Oncology Group study

(2010) Orren Beaty et al.   PEDIATRIC BLOOD & CANCER

Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors

(2009) Lisa M. McGregor et al.   CANCER

Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors

(2009) Lisa M. McGregor et al.   CANCER

A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinoma

(2008) Ji Eun Uhm et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Redefining the Role of Doxorubicin for the Treatment of Children With Hepatoblastoma

(2008) Marcio H. Malogolowkin et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I Study of Weekly Oxaliplatin in Relapsed or Refractory Pediatric Solid Malignancies

(2008) Birgit Geoerger et al.   JOURNAL OF CLINICAL ONCOLOGY